. Author manuscript; available in PMC: 2021 Aug 23.

Published in final edited form as: J Clin Psychiatry. 2021 Feb 23;82(2):20m13598. doi: 10.4088/JCP.20m13598

Table 2.

Descriptive statistics of individuals with ADHD who received ADHD pharmacotherapy or no ADHD-targeted medication. Individuals receiving ADHD pharmacotherapy were significantly older than those receiving no ADHD-targeted medication. Age is represented as the population mean in years +/− standard deviation; p-values reflect t-test or chi-squared statistical significance.

	No ADHD medication	ADHD pharmacotherapy	p-value
n	32	171
Age	32 +/− 9	38 +/− 11	p = 0.003*
Female	44%	42%	p = 0.999
White	81%	91%	p = 0.576
Private insurer	66%	64%	p = 0.999
Cocaine use disorder	31%	30%	p = 0.999